No abatement of steroid injections for tennis elbow in Australian General Practice: A 15-year observational study with random general practitioner sampling
Bill Vicenzino, Helena Britt, Allan J Pollack, Michelle Hall, Kim L Bennell, David J Hunter
PLOS ONE | PUBLIC LIBRARY SCIENCE | Published : 2017
Awarded by National Health Medical Research Council (NHMRC) Principal Research Fellowship
Awarded by NHMRC practitioner Fellowship
Awarded by NHMRC program
BEACH supporting organisations 2000-2016 include: Australian Government Department of Health (1998-2004,2007-2016); AstraZeneca Pty Ltd (Australia) (1998-2016); Sequirus Australia) Pty Ltd (2010-2016); Sanofi-Aventis Australia Pty Ltd (2006-2012,2015-16); AbbVie Pty Ltd (2014-2015); Merck, Sharp and Dohme (Australia) Pty Ltd (2002-2013); Pfizer Australia (2003-2013); National Prescribing Service Ltd (2005-2009,2012-2013); GlaxoSmithKline Australia Pty Ltd (2010-2012); Bayer Australia Ltd (2010-2011); Janssen-Cilag Pty Ltd (2000-2010); Abbott Australasia Pty Ltd (2006-2010); Wyeth Australia Pty Ltd (2008-2010); Roche Products Pty Ltd (1998-2006). KLB is supported by a National Health Medical Research Council (NHMRC) Principal Research Fellowship (APP1058440). DJH has a NHMRC practitioner Fellowship (APP1079777). MH is supported by a NHMRC program grant (#1091302). The funders had no role in any part of the study or in any decision about the publication.